Account-creators
1,040
edits
Difference between revisions of "Neuropathology tumours"
Jump to navigation
Jump to search
Neuropathology tumours (view source)
Revision as of 13:47, 11 September 2017
, 13:47, 11 September 2017→Grading: controversies...
Jensflorian (talk | contribs) |
Jensflorian (talk | contribs) (→Grading: controversies...) |
||
| Line 246: | Line 246: | ||
Notes: | Notes: | ||
*Pseudopalisading tumour cells = high tumour cell density adjacent to regions of necrosis; palisade = a fence of poles forming a defensive barrier or fortification. | *Pseudopalisading tumour cells = high tumour cell density adjacent to regions of necrosis; palisade = a fence of poles forming a defensive barrier or fortification. | ||
*WHO Grading is currently based on expected biologiocal behaviour without treatment. | |||
**Grading does not reflect molecular divergent groups within a tumor class or response to therapy (Currently controversies in grading for IDH-mutant astrocytoma vs. IDH-wildtype astrocytoma).<ref>{{Cite journal | last1 = Louis | first1 = DN. | last2 = von Deimling | first2 = A. | title = Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare. | journal = Acta Neuropathol | volume = | issue = | pages = | month = Aug | year = 2017 | doi = 10.1007/s00401-017-1765-z | PMID = 28801693 }}</ref> | |||
====Images==== | ====Images==== | ||